IL33 and infection: As we observed a negative effect of IL-33 on the gut barrier integrity during CR infection and that IL-17A supplementation limited the otherwise strong systemic spreading of the pathogen induced by IL-33, we combined the treatment with both cytokines in vivo under homeostasis and during CR infection, and assessed the intestinal permeability.